Lv1
46 积分 2025-05-27 加入
Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
1个月前
已完结
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
1个月前
已完结
Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
1个月前
已完结
Structural Basis for Accommodation of Nonsteroidal Ligands in the Androgen Receptor
1个月前
已完结
Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
1个月前
已完结
Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer
2个月前
已完结
The Blood–Brain Barrier (BBB) Score
6个月前
已完结
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer
6个月前
已完结
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING
7个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
8个月前
已完结
皖公网安备34019202002308
